Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Isolation and identification of renal cell carcinoma-derived peptides associated with GP96.

Li HZ, Li CW, Li CY, Zhang BF, Li LT, Li JM, Zheng JN, Chang JW.

Technol Cancer Res Treat. 2013 Aug;12(4):285-93. doi: 10.7785/tcrt.2012.500326. Epub 2013 Feb 22.

PMID:
23448575
2.

Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.

Hofmann S, Glückmann M, Kausche S, Schmidt A, Corvey C, Lichtenfels R, Huber C, Albrecht C, Karas M, Herr W.

Mol Cell Proteomics. 2005 Dec;4(12):1888-97. Epub 2005 Aug 19.

3.

Quantifying Gp96/Grp94 complexes preparations for vaccines: a key step often inaccurate.

Seignez A, Kohli É, Garrido C, Seigneuric R.

Curr Med Chem. 2014;21(2):153-63. Review.

PMID:
24164191
4.

Analytical challenges and strategies for the characterization of gp96-associated peptides.

Liu C, Ewing N, DeFilippo M.

Methods. 2004 Jan;32(1):32-7.

PMID:
14624875
6.

Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC).

Alves G, Pereira DA, Sandim V, Ornellas AA, Escher N, Melle C, von Eggeling F.

Int Braz J Urol. 2013 Mar-Apr;39(2):228-39. doi: 10.1590/S1677-5538.IBJU.2013.02.12.

7.

Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method.

Flad T, Spengler B, Kalbacher H, Brossart P, Baier D, Kaufmann R, Bold P, Metzger S, Blüggel M, Meyer HE, Kurz B, Müller CA.

Cancer Res. 1998 Dec 15;58(24):5803-11.

8.

Protein/RNA coextraction and small two-dimensional polyacrylamide gel electrophoresis for proteomic/gene expression analysis of renal cancer biopsies.

Barbero G, Carta F, Giribaldi G, Mandili G, Crobu S, Ceruti C, Fontana D, Destefanis P, Turrini F.

Anal Biochem. 2006 Feb 1;349(1):62-71. Epub 2005 Nov 2.

PMID:
16307718
9.

Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.

Xu G, Xiang CQ, Lu Y, Kang XN, Liao P, Ding Q, Zhang YF.

Cancer Lett. 2009 Sep 18;282(2):205-13. doi: 10.1016/j.canlet.2009.03.017. Epub 2009 Apr 11.

PMID:
19362769
10.
13.

Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen.

Linderoth NA, Simon MN, Rodionova NA, Cadene M, Laws WR, Chait BT, Sastry S.

Biochemistry. 2001 Feb 6;40(5):1483-95.

PMID:
11170476
14.

Rapid identification of comigrating gel-isolated proteins by ion trap-mass spectrometry.

Arnott D, Henzel WJ, Stults JT.

Electrophoresis. 1998 May;19(6):968-80.

PMID:
9638943
15.

Differential protein profiling in renal-cell carcinoma.

Shi T, Dong F, Liou LS, Duan ZH, Novick AC, DiDonato JA.

Mol Carcinog. 2004 May;40(1):47-61.

PMID:
15108329
16.

Structural characterization of proteins and peptides.

Deutzmann R.

Methods Mol Med. 2004;94:269-97.

PMID:
14959836
17.

Protein identification by accurate mass matrix-assisted laser desorption/ionization imaging of tryptic peptides.

Schober Y, Schramm T, Spengler B, Römpp A.

Rapid Commun Mass Spectrom. 2011 Sep 15;25(17):2475-83. doi: 10.1002/rcm.5135.

PMID:
21818808
18.

One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.

Arnold-Schild D, Kleist C, Welschof M, Opelz G, Rammensee HG, Schild H, Terness P.

Cancer Res. 2000 Aug 1;60(15):4175-8.

19.

Identification of tumor antigens in renal cell carcinoma by serological proteome analysis.

Klade CS, Voss T, Krystek E, Ahorn H, Zatloukal K, Pummer K, Adolf GR.

Proteomics. 2001 Jul;1(7):890-8.

PMID:
11503213
20.

Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry.

Verdier-Pinard P, Wang F, Burd B, Angeletti RH, Horwitz SB, Orr GA.

Biochemistry. 2003 Oct 21;42(41):12019-27.

PMID:
14556633

Supplemental Content

Support Center